Non-Opioid Pain Patches Market
Global Non-Opioid Pain Patches Market Size, Share & Trends Analysis Report, By Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Others), By Distribution Channel (Hospitals, Online Pharmacies, and Drug Stores) and Forecast, 2020-2026 Update Available - Forecast 2024-2030
The global non-opioid pain patches market is estimated to grow at a CAGR of nearly 4.5% during the forecast period. The major factors driving the market growth include the increasing number of patients with neuropathic pain and rising prevalence of cancer. Neuropathic pain occurs due to injury or malfunction in the central or peripheral nervous system. Rising incidences of spinal cord injuries and diabetes are some major causes of neuropathic pain. As per the American Diabetes Association (ADA), nearly half of all people suffering from diabetes have some kind of nerve damage and is more common in the diabetic population who are living with this disease for several years.
Diabetic neuropathy can cause pain, numbness, and weakness in hands and feet. Due to the severe side-effects associated with opioid medications, the patients and healthcare professionals are looking for alternatives that can contribute to better pain management. This is leading to increasing demand for lidocaine patches, a sodium channel blocker, that may support to modulate neuropathic pain by lowering the function of these sodium channels and reversing the effects of sodium channel upregulation. These patches are used to provide relief from the pain of post-herpetic neuralgia (neuropathic pain), such as the burning, aches, or stabbing pains, that may last for months or years.
Lidocaine is a group of drugs referred to as local anesthetics. It functions by stopping nerves from transmitting pain signals. As a patch, it applies to the skin only once a day as required for pain. Additionally, the prevalence of cancer is rising significantly, which results in the demand for chronic pain medications. As per the World Health Organization (WHO), in 2018, the global burden of cancer is estimated to have increased to 18.1 million new incidences and 9.6 million mortalities. Cancer pain is normally of mixed etiology, with neuropathic and nociceptive components. This, in turn, increases the need for neuropathy pain management for cancer patients. Topical lidocaine patches have been demonstrated to be effective for the treatment of postherpetic neuralgia and other painful peripheral neuropathies. Therefore, it can also be useful for pain management in cancer patients.
Non-Opioid Pain Patches Finds Significant Application in Hospitals
A significant number of surgeries performed in the hospitals has led to the demand for pain management medications. There is a significant rise in the number of joint replacement procedures performed across the globe. As per the Canadian Institute for Health Information (CIHI), during the period, 2017-2018, 70,502 knee replacements and 58,492 hip replacements were performed in Canada. This shows a rise of 17.0% and 17.4%, respectively, over the last 5 years. Joint replacement surgeries are also rising in other countries such as the US, India, UK, and China. Non-opioid pain patches can be used to reduce post-operative joint replacement procedures. This, in turn, is contributing to the significant application of non-opioid pain patches in hospitals.
Global Non-Opioid Pain Patches Market Share by Distribution Channel, 2019 (%)
Regional Outlook
Geographically, in 2019, North America held the largest share in the market owing to the increasing number of patients living with chronic pain in the region. As per the Centers for Disease Control and Prevention (CDC), in 2016, an estimated 20.4% of the US adults were suffering from chronic pain and 8% of the US adults were suffering from high-impact chronic pain. This is leading to increasing demand for non-opioid pain patches to minimize the intensity of all common pain qualities in patients suffering from moderate-to-severe chronic pain occurs due to postherpetic neuralgia, painful diabetic neuropathy, and low back pain.
Global Non-Opioid Pain Patches Market Growth, by Region 2020-2026
Market Players Outlook
The major players in the market include Endo International plc, Sorrento Therapeutics, Inc., Hisamitsu Pharmaceutical Co., Inc., Acorda Therapeutics, Inc. Product launches, mergers and acquisitions, and partnerships and collaborations are considered as crucial strategies adopted by the market players to expand market share and gain a competitive advantage. For instance, in March 2019, Sorrento Therapeutics, Inc. declared that its majority-owned subsidiary Scilex Pharmaceuticals Inc. closed a transaction to merge with Semnur Pharmaceuticals, Inc. to form a new company, Scilex Holding Co. With ZTlido (lidocaine topical system 1.8%), Scilex’s lead product have gained significance rapidly in the early months of commercial introduction and lead compound of Semnur (non-opioid corticosteroid gel) in Phase 3 pivotal studies to treat lumbar radicular pain/sciatica with Fast Track status from the FDA, Scilex Holding is positioned to gain significant share in non-opioid pain management.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global non-opioid pain patches market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Endo International plc
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Sorrento Therapeutics, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Hisamitsu Pharmaceutical Co., Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Acorda Therapeutics, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Sanofi S.A.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Non-Opioid Pain Patches Market by Patch Type
5.1.1. Lidocaine Patches
5.1.2. Diclofenac Patches
5.1.3. Capsaicin Patches
5.1.4. Ketoprofen Patches
5.1.5. Others
5.2. Global Non-Opioid Pain Patches Market by Distribution Channel
5.2.1. Hospitals
5.2.2. Online Pharmacies
5.2.3. Drug Stores
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Acorda Therapeutics, Inc.
7.2. AdhexPharma
7.3. Alkermes plc
7.4. Averitas Pharma, Inc.
7.5. BioElectronics Corp.
7.6. Ceramisphere Pty Ltd.
7.7. Endo International plc
7.8. GlaxoSmithKline plc
7.9. Hisamitsu Pharmaceutical Co., Inc.
7.10. IBSA Institut Biochimique SA
7.11. Mylan N.V.
7.12. Pfizer Inc.
7.13. Sanofi S.A.
7.14. Sorrento Therapeutics, Inc.
7.15. TEH SENG Pharmaceutical Mfg. Co., Ltd.
7.16. Teikoku Seiyaku Co. Ltd.
7.17. Teva Pharmaceuticals Industries Ltd.
1. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH PATCH TYPE, 2019-2026 ($ MILLION)
2. GLOBAL LIDOCAINE PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL DICLOFENAC PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL CAPSAICIN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL KETOPROFEN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL OTHER NON-OPIOID PAIN PATCHESES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
8. GLOBAL NON-OPIOID PAIN PATCHES FROM HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL NON-OPIOID PAIN PATCHES FROM ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL NON-OPIOID PAIN PATCHES FROM DRUG STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
12. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
13. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
14. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
15. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
16. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
17. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
18. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
19. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
20. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
21. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
22. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
1. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY PATCH TYPE, 2019 VS 2026 (%)
2. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY DISTRIBUTION CHANNEL, 2019 VS 2026 (%)
3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
4. US NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
5. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
6. UK NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
7. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
8. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
9. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
10. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
11. ROE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
12. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
13. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
14. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
15. REST OF ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
